IRIS
VITALE, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.975
EU - Europa 5.180
AS - Asia 776
AF - Africa 9
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
Totale 12.958
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.969
GB - Regno Unito 2.544
CN - Cina 615
IT - Italia 600
UA - Ucraina 577
SE - Svezia 519
FR - Francia 264
DE - Germania 213
IE - Irlanda 196
FI - Finlandia 134
VN - Vietnam 74
BE - Belgio 62
TR - Turchia 30
PL - Polonia 21
IN - India 18
RU - Federazione Russa 14
NL - Olanda 13
ES - Italia 11
JP - Giappone 9
PK - Pakistan 9
IR - Iran 8
AU - Australia 7
CA - Canada 6
EU - Europa 5
MA - Marocco 4
PT - Portogallo 4
BR - Brasile 3
EG - Egitto 3
SA - Arabia Saudita 3
HU - Ungheria 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
HK - Hong Kong 1
ID - Indonesia 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
SG - Singapore 1
Totale 12.958
Salva come PNG Salva come JPEG
Città #
Southend 2.458
Fairfield 1.208
Woodbridge 566
Ashburn 527
Jacksonville 473
Wilmington 471
Chandler 461
Seattle 458
Houston 445
Cambridge 416
Menlo Park 332
Ann Arbor 331
Siena 273
Princeton 231
Dublin 196
Nanjing 151
Beijing 136
San Mateo 85
Dearborn 75
Dong Ket 73
San Diego 71
Boardman 63
Brussels 58
Nanchang 58
Helsinki 56
Shenyang 41
Düsseldorf 35
Tianjin 28
Jiaxing 27
Hebei 25
Changsha 24
Izmir 24
Norwalk 21
Kraków 20
Rome 20
Washington 20
Jinan 17
Kunming 17
London 17
Milan 17
San Francisco 14
Redwood City 13
Guangzhou 12
Saint Petersburg 11
Málaga 10
Tappahannock 10
Lancaster 9
Sutri 9
Zhengzhou 9
Bologna 8
Changchun 8
Florence 8
Hangzhou 8
Lanzhou 8
Taizhou 8
Cecina 7
Falls Church 7
Venezia 7
Asciano 6
Fremont 5
Ningbo 5
Paris 5
Shanghai 5
Zanjan 5
Chicago 4
Hefei 4
Islamabad 4
Jhelum 4
Lisbon 4
Monza 4
Phoenix 4
Salerno 4
Toronto 4
Amsterdam 3
Augusta 3
Biella 3
Cagliari 3
Cortona 3
Duncan 3
Frankfurt am Main 3
Groningen 3
Labico 3
Naples 3
New York 3
Perugia 3
Pignone 3
Sacramento 3
Solofra 3
Sydney 3
São Paulo 3
Truccazzano 3
Turin 3
Venice 3
Bagno a Ripoli 2
Brindisi 2
Cairo 2
Campobasso 2
Canberra 2
Capaccio 2
Cascina 2
Totale 10.332
Salva come PNG Salva come JPEG
Nome #
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 228
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 226
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 209
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 188
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 179
Weekly oral alendronate in mevalonate kinase deficiency. 178
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 172
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 170
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 164
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 164
Working the endless puzzle of hereditary autoinflammatory disorders. 163
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 162
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 162
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 158
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 155
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 151
Untangling the Web of Systemic Autoinflammatory Diseases. 150
null 150
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 148
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 146
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. 144
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 143
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 140
The hereditary autoinflammatory disorders uncovered 137
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 137
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 137
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 135
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 135
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 134
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 132
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 132
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 132
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 132
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. 131
null 131
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman 130
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 130
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 129
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives 128
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 124
null 121
Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms 121
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 121
Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma 120
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up. 119
null 119
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 119
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 119
null 118
Clinical and biochemical landmarks in systemic autoinflammatory diseases 117
null 117
null 116
The role of the F402L allele in the NLRP12-autoinflammatory disorder. Reply to: F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls, De Pieri et al 116
null 115
null 115
Serum amyloid-A in Behçet's disease. 115
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome. 115
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 114
Diagnosis and classification of relapsing polychondritis. 114
null 113
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined. 112
null 112
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series. 111
Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab 109
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 109
null 107
null 107
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review 106
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 106
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 105
null 104
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. 104
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 103
null 102
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 100
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 100
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 99
Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 99
null 98
Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa 98
Anakinra long-term efficacy and safety in the management of Schnitzler's syndrome and latent tuberculosis infection 95
null 95
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 95
null 94
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 93
Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series 90
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 88
Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers 87
Evolving Frontiers in the Treatment of Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) Syndrome 84
The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review. 81
Interleukin-1: Ariadne's Thread in Autoinflammatory and Autoimmune Disorders 81
Successful use of canakinumab in a patient with resistant Behçet's disease 78
Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis. 78
Efficacy of anakinra in refractory Behçet's disease sacroiliitis 77
Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series 76
null 76
Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report. 74
Interleukin-1 Inhibition in Behçet's disease 70
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 69
Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases 69
Totale 12.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.869
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.136 0 0 208 86 103 385 156 122 90 191 385 410
2019/20203.099 354 142 175 431 166 275 261 373 311 320 104 187
2020/20212.660 246 259 108 219 189 351 104 396 118 263 153 254
2021/20221.904 182 231 116 132 102 35 82 63 141 229 205 386
2022/20231.821 115 150 241 218 169 339 63 143 211 31 85 56
2023/2024298 83 53 162 0 0 0 0 0 0 0 0 0
Totale 13.332